Bio Green Med Solution, Inc. — Director's Dealing 2013

May 23, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cyclacel Pharmaceuticals, Inc. (CYCC)
CIK: 0001130166
Period of Report: 2013-05-22

Reporting Person: Hradsky Gregory T. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-05-22	Option	$2.99	A	3571	Acquired	2023-05-22	Common Stock (3571)	Direct

Footnotes

F1: These options are exercisable over a four-year period with 1/48 of the options granted vesting on a monthly basis.

F2: These options were granted to Mr. Hradsky for his services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc.